Actively Recruiting
Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
Led by IRCCS San Raffaele · Updated on 2026-03-17
50
Participants Needed
1
Research Sites
222 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project aims to provide an accurate strategy to guide the decision making relying on tumor biopsies using standard histology, immunohistochemistry (IHC), spatial transcriptomics, genomics combined with Magnetic Resonance Imaging (MRI) and radiomics. Moreover, the investigators will explore potential markers indicative of response to systemic agents or ablative therapy.
CONDITIONS
Official Title
Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence of a renal mass up to 4 cm
- Adult > 18 years
- Candidate to renal surgery
- Informed consent signed
You will not qualify if you...
- Contraindication for MRI
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Ospedale San Raffaele
Milan, Italia, Italy, 20132
Actively Recruiting
Research Team
U
Umberto Capitanio
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here